-
Product Insights
NewCorneal Edema – Drugs In Development, 2024
Empower your strategies with our Corneal Edema – Drugs In Development, 2024 report and make more profitable business decisions. Corneal edema is the swelling of the cornea due to the accumulation of extracellular fluid in epithelium and stroma resulting in loss of corneal transparency. The Corneal Edema drugs in development market research report provide comprehensive information on the therapeutics under development for Corneal Edema, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA),...
-
Product Insights
NewCorneal Dystrophy – Drugs In Development, 2024
Empower your strategies with our Corneal Dystrophy – Drugs In Development, 2024 report and make more profitable business decisions. Corneal dystrophy (CD) is defined as a collection of rare hereditary non-inflammatory disorders of abnormal deposition of substances in the cornea. The material may cause the cornea to lose its transparency and can cause loss of vision or blurred vision. Corneal dystrophies can appear at any age and men and women are equally affected by most corneal dystrophies. The symptoms of corneal...